Business-as-Usual will not Deliver the COVID-19 Vaccines We Need

Els Torreele ()
Additional contact information
Els Torreele: University College London

Development, 2020, vol. 63, issue 2, 191-199

Abstract: Abstract Governments must become active shapers of medical innovation and drive the development of critical health technologies as global health commons. The ‘race’ for COVID-19 vaccines is exposing the deficiencies of a business-as-usual medical innovation ecosystem driven by corporate interests, not health outcomes. Instead of bolstering collective intelligence, it relies on competition between proprietary vaccines and allows the bar on safety and efficacy to be lowered, risking people’s health and undermining their trust.

Keywords: Medical innovation; R&D governance; Vaccination; Collective intelligence; Open science; Transparency; Vaccine safety and efficacy (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1057/s41301-020-00261-1 Abstract (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:develp:v:63:y:2020:i:2:d:10.1057_s41301-020-00261-1

Ordering information: This journal article can be ordered from
http://www.springer. ... es/journal/41301/PS2

DOI: 10.1057/s41301-020-00261-1

Access Statistics for this article

Development is currently edited by Stefano Prato

More articles in Development from Palgrave Macmillan, Society for International Deveopment Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().